Bruno Paquin

Bruno Paquin has a diverse work experience spanning various roles and companies.

Since 2022, they have been serving as the Chief Executive Officer at AtomVie Global Radiopharma Inc.

From 2018 to 2022, Bruno held multiple roles at Centre for Probe Development and Commercialization, including CEO, Interim Chief Executive Officer, Senior Director Business Development, and Director, Business Development.

Prior to that, from 2011 to 2018, they were the VP of Business Development at Immuni T.

Bruno also has experience with Genizon Biosciences, where they served as a Consultant, Executive Director, Business Development, Executive Director, Head of Business Development, Executive Director Business Development, Director, Science & Technology Liaison, and Head, Technology Development Unit, from 2000 to 2011.

Before that, they worked as a Research Affiliate (Interim PI) at Université de Montréal from 1998 to 2000.

Bruno Paquin holds a Ph.D. in Biochemistry from the Université de Montréal. No further information about their education history is available.